
Scout
Scout is a YC Winter 2022 (W22) company. Based in Santa Clara, CA, USA. Team of 12.
About Scout
Summary
Scout builds a portable molecular diagnostic platform, combining a hardware hub, test kits, and a companion app, that lets patients and clinicians run PCR-grade tests at home or at the point of care in under 30 minutes. It targets primary care, sexual health, respiratory illness, and chronic disease screening, replacing the choice between fast-but-inaccurate lateral flow tests and slow central-lab PCR. The platform is designed to plug into existing healthcare technology infrastructure, cutting the cost and time traditionally required to bring a new diagnostic test to market.
Business model
Per-test pricing on consumable test kits used with the Scout Hub device.
Go-to-market
Scout targets clinicians, health systems, and patients seeking home or point-of-care diagnostics; the company is building a waitlist ahead of its commercial hub launch and pursues institutional partnerships with health systems and research universities.
From the Y Combinator listing
The smart testing platform that unlocks digital health at home.
Digital health holds a lot of potential but is ignoring a growing problem: diagnostic testing. Without this data, providers and organizations will be limited in the services they can provide patients at home. Scout has developed a platform - Hub, test kits, and app - that delivers health testing at home with 10x lower development cost and 3x lower per-test price. Our patented tech also meets performance requirements for medical diagnoses and integrates with the current healthcare tech stack. Scout’s technology is poised to disrupt the outdated $33Bn diagnostic market by democratizing testing while dramatically improving the patient experience. Scout has received $16M in non-dilutive funding from the NIH and other organizations to fully de-risk our platform, and our pipeline includes a diverse test menu for primary care (e.g. respiratory and sexual health), wellness (e.g. gut health), and chronic conditions (e.g. certain cancers). We have already received FDA authorization for our platform in clinical settings and are planning to launch our flagship Scout Hub in 2024.
Facts
- Healthcare / Healthcare -> Diagnostics
- Santa Clara, CA, USA
- 12
- Active
- Early
Founders (2)
- Alex Jiao
- Cameron Ball
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works